Literature DB >> 15687407

Abdominal obesity and expression of familial combined hyperlipidemia.

Carla J H van der Kallen1, Christine Voors-Pette, Tjerk W A de Bruin.   

Abstract

OBJECTIVE: To investigate the role of abdominal and body obesity on the prevalence of hyperlipidemia, in particular, hypertriglyceridemia, hypercholesterolemia, and high apolipoprotein B levels, in familial combined hyperlipidemia (FCHL) relatives and their spouses. RESEARCH METHODS AND PROCEDURES: In FCHL relatives (n = 618) and spouses (n = 297), prevalence data of hyperlipidemia and high apolipoprotein B levels and their age and gender-corrected odds ratios (ORs) were calculated for sex-adjusted categories of waist-to-hip ratio (WHR), waist circumference, and BMI.
RESULTS: Increments of BMI, waist circumference, and WHR increased the frequency of hyperlipidemia. In the whole study population (relatives and spouses combined), frequency of hypertriglyceridemia showed a significant interaction only between WHR categories and FCHL. This was studied further after stratification of relatives by multivariable logistic regression analyses corrected for age and gender. Predominant expression of hypertriglyceridemia was observed with higher categories of WHR in FCHL relatives (prevalence up to 57.6%, OR 8.48 in highest vs. lowest WHR category, p < 0.001) but not in spouses (up to 32.9%, OR 1.05 in highest vs. lowest WHR category, not significant). DISCUSSION: Both in spouses and FCHL relatives, increments in BMI and waist circumference increased the prevalence of hyperlipidemia. Specifically, in FCHL relatives, WHR was the most informative determinant of the expression of hyperlipidemia, in particular, hypertriglyceridemia. The data indicate that FCHL develops against a background of abdominal obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15687407     DOI: 10.1038/oby.2004.256

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  6 in total

1.  Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia.

Authors:  Rocio Mateo-Gallego; Maria Solanas-Barca; Elena Burillo; Ana Cenarro; Iva Marques-Lopes; Fernando Civeira
Journal:  J Physiol Biochem       Date:  2010-07-20       Impact factor: 4.158

2.  Impaired endothelium-dependent vascular reactivity in patients with familial combined hyperlipidaemia.

Authors:  M De Michele; A Iannuzzi; A Salvato; P Pauciullo; M Gentile; G Iannuzzo; S Panico; A Pujia; G M Bond; P Rubba
Journal:  Heart       Date:  2006-06-28       Impact factor: 5.994

3.  Predictive factors for pancreatic fistula after pancreaticosplenectomy for advanced gastric cancer in the upper third of the stomach.

Authors:  Chikara Kunisaki; Hiroshi Shimada; Hidetaka Ono; Yuichi Otsuka; Goro Matsuda; Masato Nomura; Hirotoshi Akiyama
Journal:  J Gastrointest Surg       Date:  2006-01       Impact factor: 3.267

4.  Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.

Authors:  Sukma Azureen Nazli; Yung-An Chua; Noor Alicezah Mohd Kasim; Zaliha Ismail; Ahmad Bakhtiar Md Radzi; Khairul Shafiq Ibrahim; Sazzli Shahlan Kasim; Azhari Rosman; Hapizah Nawawi
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

Review 5.  Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.

Authors:  Antonio Gaddi; A F G Cicero; F O Odoo; A A Poli; R Paoletti
Journal:  Vasc Health Risk Manag       Date:  2007

6.  Dietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone.

Authors:  David M Diamond; Abdullah A Alabdulgader; Michel de Lorgeril; Zoe Harcombe; Malcolm Kendrick; Aseem Malhotra; Blair O'Neill; Uffe Ravnskov; Sherif Sultan; Jeff S Volek
Journal:  BMJ Evid Based Med       Date:  2020-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.